Bempeg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bempeg, covering 2024-06-27 to 2024-06-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer [Phase 3]